Literature DB >> 28861342

MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.

Xiao-Lei Shao1,2, Yao Chen1, Ling Gao1.   

Abstract

AIM: To analyze the relationship between clinical features and epithelial mesenchymal transition (EMT) in retinoblastoma (RB), further to investigate whether miR-200c regulates the EMT and migration of RB cells.
METHODS: Expression of EMT-related markers and tumor-related factors were detected by immuno-histochemistry analysis in RB tissue from 29 cases. Correlations between their expression and clinical characteristics were analyzed. The regulation effects of miR-200c on EMT-related markers, tumor-related factors were observed in mRNA level and protein level by real-time polymerase chain reaction (PCR) and Western blot, respectively, in Y79 and Weri-rb1 cells. Its effects on migration force of these RB cell lines were also detected with Transwell test.
RESULTS: Lower expression of E-cadherin was present in the cases with malignant prognosis. MiR-200c promoted the expression of E-cadherin and decreased the expression of Vimentin and N-cadherin in Y79 and Weri-rb1 cells. Migration force of RB cells could be inhibited by miR-200c.
CONCLUSION: EMT might be associated with bad prognosis in RB. MiR-200c suppresses the migration of retinoblastomatous cells by reverse EMT.

Entities:  

Keywords:  E-cadherin; epithelial mesenchymal transition; miR-200c; retinoblastoma

Year:  2017        PMID: 28861342      PMCID: PMC5554835          DOI: 10.18240/ijo.2017.08.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  37 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Epithelial-mesenchymal transition: clinical implications for nodal metastasis and prognosis of tongue cancer.

Authors:  Myung Woul Han; Jong Cheol Lee; Young Min Kim; Hee Jeong Cha; Jong-Lyel Roh; Seung-Ho Choi; Soon Yuhl Nam; Kyung-Ja Cho; Seong Who Kim; Sang Yoon Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-11       Impact factor: 3.497

3.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

Review 4.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

5.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

Authors:  Shujing Liu; Michael T Tetzlaff; Rutao Cui; Xiaowei Xu
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

Review 6.  Oncogenic microRNAs in the genesis of leukemia and lymphoma.

Authors:  Yanyan Pan; Mei Meng; Gaochuan Zhang; Hongyan Han; Quansheng Zhou
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

Authors:  S Detre; G Saclani Jotti; M Dowsett
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

8.  miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.

Authors:  Lei Liu; Mingning Qiu; Guobin Tan; Ziji Liang; Yue Qin; Lieqian Chen; Hege Chen; Jianjun Liu
Journal:  J Transl Med       Date:  2014-11-04       Impact factor: 5.531

9.  MiR-630 suppresses breast cancer progression by targeting metadherin.

Authors:  Ci-Xiang Zhou; Chen-Long Wang; An-Lu Yu; Qiu-Yu Wang; Meng-Na Zhan; Jun Tang; Xiu-Feng Gong; Qian-Qian Yin; Ming He; Jian-Rong He; Guo-Qiang Chen; Qian Zhao
Journal:  Oncotarget       Date:  2016-01-12

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  3 in total

1.  SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma.

Authors:  Hui Wang; Xiang Ji
Journal:  Cancer Cell Int       Date:  2020-01-22       Impact factor: 5.722

Review 2.  The role of microRNAs in COVID-19 with a focus on miR-200c.

Authors:  Hadi Sodagar; Shahriar Alipour; Sepideh Hassani; Shiva Gholizadeh-Ghaleh Aziz; Mohammad Hasan Khadem Ansari; Rahim Asghari
Journal:  J Circ Biomark       Date:  2022-03-21

3.  miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN.

Authors:  Yang Hu; Ming Zhao; Li Li; Jie Ding; Yu-Min Gui; Tan-Wei Wei
Journal:  Biochem Genet       Date:  2020-10-23       Impact factor: 1.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.